Ovarian cancer immune cells under microscope in terminated study
NCT ID NCT03922776
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to understand how immune cells in the blood, abdominal fluid, and tumor tissue change in women with advanced ovarian or fallopian tube cancer before and after chemotherapy. Researchers collected samples from 36 women to count different types of immune cells. The study was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER STAGE IIIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Microchip implanted in tumors could personalize ovarian cancer treatment
- New antibody combo shows promise for tough ovarian cancer
- New vaccine combo aims to outsmart ovarian cancer resistance
- Pre-Surgery boot camp for cancer patients shows promise
- Cherry juice tested as shield against chemo nerve pain
- Exercise may ease nerve pain and keep legs strong in ovarian cancer patients on chemo